baber/WOPTO huggingface dataset:
Patent GB-1353018-A (GB)
Title: Automatic transversal equalizer
IPC: H04B3/04
Filed: 1970-04-21
Abstract: 1353018 Automatic equalizers XEROX CORP 20 April 1971 [21 April 1970] 19039/70 Heading H4R An automatically adjusting equalizer has a transversal filter with its taps fixed to give an amplitude frequency response having a rising characteristic, following a raised cosine curve, between 600 and 3000 Hz. The output, 30, from the transversal filter is fed via a potentiometer 56 to a summing amplifier where it is added to the signal appearing at the centre tapping 40, of the transversal filter delay line. The potentiometer is automatically adjusted to provide equalization for two different frequency pilot signals transmitted over the transmission system and fed through the equalizer. As described with respect to Fig. 8 the full equalizer comprises a transversal filter including delay line sections T with the signal appearing at the input, output, and middle, taps fed through respective resistors 24, 26, 28, to an inverting amplifier 50. The output of amplifier 50 is mixed with the signal appearing at the two other taps, fed through respective resistors 25, 27, at the input to a second inverting amplifier 54. The resulting signal, constituting the output of the transversal filter, is fed through a variable resistor 56 to be mixed with the signal appearing at the centre tap of the filter at the input of a third amplifier 58, the output from which constitutes the equalizer output. The received signal includes two reference or pilot signals at 1200 and 2400 Hz, the relative levels of which, at the transmitter, are known; these reference signals are separated by filters 67 and 68, amplified, and rectified to provide opposing D.C. voltages at the input of amplifier 72 to provide a control signal for driving motor 73 in such a way as to adjust potentiometer 56 to restore the relative levels of the two pilots to the values they had at the transmitter.
Patent ID-29428-A (ID)
Inventor: BENJAMIN R
IPC: C11D11/04
Filed: 1999-11-16
Abstract: A low total fatty matter content detergent bar composition comprising a surfactant 25-70% total fatty matter, 9-16% by weight colloidal aluminium hydroxide and 12-52% water. The invention also comprises a process for preparing a detergent bar comprising a surfactant, 25-70% total fatty matter, 0.5-20% colloidal aluminium hydroxide and 15-52% water, comprising the steps of reacting one or more fatty acids or fats with sodium aluminate with a solid content of 20-55% wherein the Al2O3 to Na2O ratio is in the region 0.5-1.55:1 to obtain a mixture of aluminium hydroxide and soap at a temperature of between 40° C. and 95° C., adding a predetermined amount of water to the mixture of aluminium hydroxide and soap, adding any further minor additives, and converting the product into bars.
Patent IL-100535-A (IL)
Title: Pharmaceutical compositions containing xanthine derivatives for alleviating disease states
IPC: C07D473/04
Filed: 1987-12-23
Abstract: A family of compounds effective in the inhibiting interleukin-1 activity is identified as <CHEM> The inhibition of IL-1 in mammals is implicated in alleviation of a wide variety of diseased conditions.
Patent IL-105366-A (IL)
Title: Compositions for the treatment of diseases with interferon while reducing side effects
IPC: A61K38/00
Filed: 1993-04-13
Abstract: Methods for the treatment of cell proliferation disorders, viral infections, and other conditions without causing significant side effects normally associated with interferon therapy, involving administering to a patient in need thereof a therapeutically effective amount of consensus human leukocyte interferon are disclosed. Also disclosed are pharmaceutical compositions of consensus human leukocyte interferon.
Patent IL-105888-A (IL)
Title: Thiosemicarbazonic acid esters
IPC: A61K31/425
Filed: 1993-06-02
Abstract: The invention relates to novel thiosemicarbazonic acid esters of the formula I <IMAGE> in which R1 and R5 denote lower alkyl, lower alk-2-en-1-yl or alternatively lower alk-2-yn-1-yl, R2 and R3 independently of one another denote hydrogen or lower alkyl or together represent lower alkylidene and R4 denotes lower alkyl, lower alkoxy, lower alk-2-en-1-yl, lower alk-2-yn-1-yl, aryl-lower alkyl, aryl-lower alkenyl, or alternatively lower alkoxycarbonyl-lower alkyl and their salts and tautomeric compounds and double bond isomers, processes for the preparation of the compounds mentioned, pharmaceutical preparations containing these and their use as pharmaceutical active compounds.
[EP0573391A1]
Patent IL-108056-A (IL)
Title: Radio telephone system for minimizing co-channel interference utilizing geographic separation of signals and transmission power control
Inventor: MORDECHAI RITZ
IPC: H04B7/005
Filed: 1993-12-16
Abstract: A system for minimizing co-channel interference between transmission sectors at their common periphery. The system exploits the geographic separation of potentially interfering mobile transmitters (12) and utilizes transmission power control. The system employs sectored antennas in a combined frequency hopping, TDMA system wherein each subscriber in a particular sector is assigned a time slot in the system based upon that subscriber's geographic location within that sector. The transmission power in the sector is reduced during certain predetermined time slots and subscribers who are remote from the fringe of the sector are assigned to these power reduced time slots. During up-link the transmission power for subscribers located proximal to the fringe are reduced to cause less co-channel interference between their signals and the signals from other subscribers in different sectors having the same time slot.
Patent IL-110323-A (IL)
Title: Contact lens inspection apparatus and lens mold for use in such apparatus
IPC: B29D11/00
Filed: 1994-07-14
Abstract: A lens mold includes first (1) and second mold (2) members respectively having a concave (3) surface and a convex surface (4) for defining therebetween a lens cavity. One of the first and second mold members is configured to mechanically engage a ring of excess lens material upon polymerization of the lens material. Alternately, one of the first and second mold members includes a material formed along the periphery of a lens cavity (5) which causes the ring of excess lens material thereto. Furthermore, one of the first and second mold members is formed of a relatively transparent plastic material and includes an outer surface having an optical finish to permit optical inspection of a lens located on one of the concave and convex surfaces. Alternately, one of the first and second mold members is formed of a relatively opaque plastic material and includes an inner surface having an optical finish to permit optical inspection of a lens located on one of the concave and convex surfaces. <IMAGE>
Patent IL-118150-A (IL)
Title: Isolating and culturing schwann cells
IPC: A61K35/30
Filed: 1996-05-05
Abstract: A method for enhancing the survival and/or proliferation of Schwann cells (especially human Schwann cells) in cell culture is disclosed which involves culturing the cells in serum free culture medium comprising gas6 and other mitogenic agents, such as heregulin and forskolin. The culturing step is generally preceded by a pre-incubation period wherein nerve tissue comprising the Schwann cells is cultured under appropriate conditions and for a period of time such that demyelination occurs. The isolated Schwann cells can be used as cellular prostheses to treat patients with nervous system injuries. The invention also provides a cell culture medium for culturing Schwann cells.
Patent IL-121796-A (IL)
Title: Seal for coupling and connecting means
Inventor: CHIPROOT AVI
IPC: F16L25/14
Filed: 1997-09-18
Abstract: An outer ring (1) is detachably joined to at least one inner ring (5) so that they are separable. The outer ring is integral with the inner ring or rests against the outside of the inner ring. The outer ring at least is hollow (3). A U shaped ring can contain the sealing ring as connection.
Patent IL-122447-A (IL)
Title: Anaesthetic pharmaceutical composition for use on mucous membranes
IPC: A61K47/10
Filed: 1997-04-01
Abstract: A pharmaceutical composition comprising (i) one or more local anaesthetics in oil form; (ii) one or more surfactants, in an amount effective to produce a homogeneous formulation wherein at least one surfactant has thermoreversible gelling properties; and (iii) water; wherein said composition is in the form of an emulsion or microemulsion and has thermoreversible gelling properties such that said composition is less viscous at room temperature than after application onto a mucous membrane of a patient. 115 ז' באייר התשס" א - April 30, 2001
Patent IL-123784-A (IL)
Title: Method for extracting deformations from velocity-encoded magnetic resonance images of the heart
IPC: G01R33/567
Filed: 1998-03-23
Abstract: A method for producing an image with an MRI system which indicates the deformation of a moving organ, the steps comprising: (a) acquiring velocity image data of the organ with the MRI system using a pulse sequence which employs a velocity encoding gradient; (b) reconstructing a velocity image from the acquired velocity image data; (c) calculating the rigid body motion of the organ using data acquired with the MRI system; (d) producing the image indicative of organ deformation by subtracting the rigid body motion from the velocity image.
Patent IL-129019-A (IL)
Title: Space frame for vehicle
IPC: B60R21/13
Filed: 1997-09-17
Abstract: A space frame for a low profile, light truck with triangulation members of the space frame located under the floor is described having a passenger compartment, and front and rear wheel assemblies. The space frame comprises a front clip portion above the front wheel assembly, a rear clip portion above the rear wheel assembly, and a tub portion supporting the base of the passenger compartment. The tub portion includes a plurality of structural members at least two of which are disposed in horizontal coplanar relation relative to one another wherein additional structural members of the tub portion are connected together in a triangulated configuration at an elevation at or below the at least two horizontal coplanar structural members of the tub portion. Foldable rollbars are also provided.
Patent IL-130660-A (IL)
Title: Benzothiophene-carboxamide derivatives and pgd2 antagonists comprising them
IPC: C07D333/70
Filed: 1997-12-10
Abstract: A compound of the formula 479 כ" ו באדר התשס" ב - March 10, 2002 R represents hydrogen, alkyl, alkoxy, halogen, hydroxy, acycloxy or optionally substituted arylsulfonyloxy, X represents hydrogen or alkyl, and the double bond on the a-chain has E configuration or Z configuration, provided that the compound of the formula: wherein R1a represents hydrogen, alkyl or alkoxy, X is as defined above, and the double bond on the a-chain has E configuration or Z configuration is excluded, a pharmaceutically acceptable salt thereof, or hydrate thereof.
Patent IL-131063-A (IL)
Title: Bistable spring construction for a stent and other medical apparatus
IPC: A61F2/06
Filed: 1998-01-23
Abstract: The present invention is directed to bistable cells and their use in devices, particularly medical devices such as stents (50), clamps and valves. An expandable stent formed of a plurality of bistable cells (52,54) is described. The stent has two or more stable configurations, including a first stable configuration with a first diameter and a second stable configuration with a second, larger diameter.
Patent IL-136804-A (IL)
Title: Opioid agonist/antagonist combinations
Inventor: COLUCCI ROBERT D
IPC: A61K9/22
Filed: 2000-06-15
Abstract: The invention relates to oral dosage forms comprising a combination of an orally analgesically effective amount of an opioid agonist and an orally active opioid antagonist, the opioid antagonist being included in a ratio to the opioid agonist to provide a combination product which is analgesically effective when the combination is administered orally, but which is aversive in a physically dependent subject when administered at the same dose or at a higher dose than the usually prescribed dose of opioid agonist.
Patent IL-137746-A (IL)
Title: Diisopropyl fluorophosphatase and the utilization and production thereof
IPC: C12N1/19
Filed: 2000-08-08
Abstract: The present application relates to a diisopropyl-fluorophosphatase from Loligo vulgaris, and to the amino acid and nucleic acid sequences encoding the enzyme. Also provided are vectors which contain the DNA sequence according to the invention, and to cells transformed with the base sequence according to the invention. Finally, the present application also provides a method for the production of the diisopropyl-fluorophosphatase and various types of use and areas of employment of the diisopropyl-fluorophosphatase, in particular the decontamination of contaminated habitats, the production of medicinal products for treating or detoxifying humans and animals, the impregnation of clothing and the use in analyses.
Patent IL-138224-A (IL)
Title: Security system
IPC: G08B/
Filed: 2000-09-03
Abstract: A monitoring system 10 is provided which includes a primary electronic tag 12, a secondary electronic tag 16, reading apparatus 20, and a comparator 26. The primary electronic tag 12 includes primary identification data associated with the primary bearer 14 of the tag 12 and the secondary electronic tag 16 includes secondary identification data. The secondary identification data is associated with a secondary bearer 18 of the tag 16 and is also associated with the primary identification data. The reading apparatus 20 remotely reads the primary and secondary identification data and the comparator 26 compares the data and generates an output signal dependent upon the outcome of the comparison. The invention extends to a primary electronic tag 12 for use in monitoring movement of at least one secondary electronic tag 16. The invention also extends to a method of monitoring movement from a selected zone and a method of monitoring the use of at least one vehicle.
Patent IL-140475-A (IL)
Title: Device for the treatment of erectile dysfunction, method of preparation and use thereof
IPC: A61K9/00
Filed: 2000-12-21
Abstract: Devices and methods for treatment of erectile dysfunction and methods of manufacture and of use are provided. The devices include filmogenic material, a therapeutic agent, a permeation enhancer, and other ingredients. An embodiment of the device includes a backing and a release liner.
Patent IL-142334-A (IL)
Title: Methods and compositions for the prevention and treatment of anemia
IPC: C12N15/12
Filed: 2001-03-29
Abstract: Methods for increasing and maintaining hematocrit in a mammal comprising administering a hyperglycosylated analog of erythropoietin are disclosed. An analog may be administered less frequently than an equivalent molar amount of recombinant human erythropoietin to obtain a comparable target hematocrit and treat anemia. Alternatively, a lower molar amount of a hyperglycosylated analog may be administered to obtain a comparable target hematocrit and treat anemia. Also disclosed are new hyperglycosylated erythopoietin analogs, methods of production of the analogs, and compositions comprising the analogs.
[WO0024893A2]
Patent IL-150608-A (IL)
Title: System and method for using an ip address as a wireless unit identifier
IPC: H04L12/56
Filed: 2002-07-04
Abstract: A first network access point receives a first wireless link message from a first user terminal. The first wireless link message identifies the first user terminal. The first network access point or other system entity assigns an IP address to the first user terminal for use as a temporary mobile station identifier. The first network access point or other system entity installs a route for the IP address to a controller. The first network access point forwards a wireless link message to the user terminal specifying the IP address. The first or a second network access point receives another wireless link message from the first user terminal in which the first user terminal is identified with the IP address. The first or second network access point parses the message to determine the IP address and creates at least one standard IP packet designating the IP address specified in the message. The first or second network access point forwards the message to a router which routes the packet according to the IP address.
Patent IL-154248-A (IL)
Title: Antibody against melanoma-inhibiting protein
IPC: C12N/
Filed: 1994-07-20
Abstract: New protein (I) with melanoma-inhibiting activity inhibits growth of cell lines HTZ 19-dm and ATCC CRL 1424. It is encoded by (a) 459 bp cDNA (IIa) or the corresponding 3565 bp genomic sequence (IIb), both reproduced in the specification, encoding a 131 amino acid protein which includes a 24 amino acid signal peptide, or (b) DNA sequences, or their fragments, able to hybridise with (IIa) or (IIb) in the region encoding the mature protein. Also new are (1) HTZ 19-dm (DSM ACC 2133); (2) (IIa) and (IIb), also sequences complementary to them, able to hybridise with them, or equiv. within the degeneracy of the genetic code; (3) recombinant expression vectors contg. such DNA and able to express (I) in transformed microorganisms or eukaryotic cells; (4) prokaryotic and eukaryotic cells able to express (I); (5) antibodies (Ab) raised against (I).
Patent IL-154250-A (IL)
Title: Vaccine against host cell-associated herpes viruses comprising a viral recombinant genome
Inventor: FEHLER FRANK
IPC: C12N1/21
Filed: 2003-02-02
Abstract: The invention relates to the field of so-called host cell-associated herpesviruses such as Marek's disease like virus (MDV) of poultry and of Varicella Zoster Virus (VZV) of man and to vaccination against disease caused by these viruses. The invention provides a vaccine directed against an infection caused by an herpesvirus that is essentially host cell associated comprising a recombinant viral genome derived from said herpesvirus, said genome allowing recombination essentially free of said host cell.
Patent IL-157443-A (IL)
Title: Compositions comprising a chemotherapeutic agent and epothilone analog and uses thereof
IPC: A61K33/24
Filed: 2003-08-18
Abstract: Compositions and methods are disclosed which are useful of the treatment and prevention of proliferative disorders.
Patent IL-162801-A (IL)
Title: Preparation for wound healing and prevention of bandage adhesion to the wound
IPC: A61L15/28
Filed: 2003-01-15
Abstract: Preparation for wound healing and prevention of adhesion to the wound containing a physiologically acceptable salt of hyaluronic acid, iodine and potassium iodine.
Patent IL-169797-A (IL)
Title: 3-substituted-2 (arylalkyl)-1- azabicycloalkanes and pharmaceutical compositions comprising them
IPC: C07D453/04
Filed: 2005-07-20
Abstract: The present invention relates to 3-substituted-2-(arylalkyl)-1-azabicycloalkanes, methods of preparing the compounds and methods of treatment using the compounds. The azabicycloalkanes generally are azabicycloheptanes, azabicyclooctanes, or azabicyclononanes. The aryl group in the arylalkyl moiety is a 5- or 6-membered ring heteroaromatic, preferably 3-pyridinyl and 5-pyrimidinyl moieties, and the alkyl group is typically a C1-4 alkyl. The substituent at the 3-position of the 1-azabicycloalkane is a carbonyl group-containing moiety, such as an amide, carbamate, urea, thioamide, thiocarbamate, thiourea or similar functionality. The compounds exhibit activity at nicotinic acetylcholine receptors (nAChRs), particularly the alpha7 nAChR subtype, and are useful towards modulating neurotransmission and the release of ligands involved in neurotransmission. Methods for preventing or treating conditions and disorders, including central nervous system (CNS) disorders, which are characterized by an alteration in normal neurotransmission, are also disclosed. Also disclosed are methods for treating inflammation, autoimmune disorders, pain and excess neovascularization, such as that associated with tumor growth.
Patent IL-171745-A (IL)
Title: Projection optical system, exposure apparatus, exposure method and device manufacturing method
Inventor: OMURA YASUHIRO
IPC: G03F7/20
Filed: 2005-11-02
Abstract: A catadioptric projection optical system for forming a reduced image of a first surface (R) on a second surface (W) is a relatively compact projection optical system having excellent imaging performance as well corrected for various aberrations, such as chromatic aberration and curvature of field, and being capable of securing a large effective image-side numerical aperture while suitably suppressing reflection loss on optical surfaces. The projection optical system comprises at least two reflecting mirrors (CM1, CM2), and a boundary lens (Lb) whose surface on the first surface side has a positive refracting power, and an optical path between the boundary lens and the second surface is filled with a medium (Lm) having a refractive index larger than 1.1. Every transmitting member and every reflecting member with a refracting power forming the projection optical system are arranged along a single optical axis (AX) and the projection optical system has an effective imaging area of a predetermined shape not including the optical axis.
Patent JP-S5724485-A (JP)
Title: Vane pump
Inventor: MOCHIZUKI NORIHIRO
IPC: F04C11/00
Filed: 1980-07-22
Abstract: PURPOSE: To simplify the construction of a vane pump by a method wherein a pump housing having a sliding contact surface for a rotor and defining a high-pressure chamber therein is unitedly clamped to a cam ring which holds a rotor in a cam hole, and the assembly is fitted in a reservoir tank in a sealed manner.  
     CONSTITUTION: The pump housing 22 having the sliding contact surface for the rotor 23 and defining the high-pressure chamber 30 therein is unitedly clamped to the cam ring 25 which holds the rotor 23 in the cam hole in cooperation with a cover plate 26, to constitute a pump main body 1. The main body 1 is fitted in a bottomed cylindrical reservoir tank 21 in a sealed manner. By this constitution, springs for securing oil-tightness of an operating chamber at the time of starting operation and an oil seal for partitioning are unnecessitated, resulting in a simpler construction. 
     COPYRIGHT: (C)1982,JPO&Japio
Patent JP-S5433957-A (JP)
Title: Disc brake
Inventor: YOSHIDA TERUAKI
IPC: F16D55/224
Filed: 1977-08-23
Abstract: PURPOSE: To obtain a disc brake with increased capacity by the use of a second caliper cylinder on the brake caliper. 
     COPYRIGHT: (C)1979,JPO&Japio
Patent JP-S5528417-A (JP)
Title: Continuous operation method of exhaust gas denitration process
Inventor: SASAKI TAKASHI
IPC: B01D53/94
Filed: 1978-08-17
Abstract: PURPOSE: To continuously operate this process over a long period while fixedly keeping the desired denitration coefficient continually, in an operation method of this exhaust gas denitration process for making notrogen oxides in exhaust gas harmless by means of an ammonia catalytic reduction method.  
     CONSTITUTION: This process is operated in order to reduction remove notrogen oxides in such a manner that ammonia from an ammonia supply source U is introduced to an exhaust gas drawing line α joining a generating source P of exhaust gas, in which the concentration of nitrogen oxides contained, the quantity of gas generated and/or the temperature of gas generated change, and an exhaust gas denitration device Q through a control valve a 4  controlled in response to the output of a computing element a 3 , to which signals from a nitrogen oxide concentration measuring meter a 1 , an exhaust gas flow-rate measuring meter a 2 , an exhaust gas temperature meansuring meter a 5 , etc. are input, and a line ω. When no reaching to the desired denitration coefficient is detected by means of a measuring meter Z in a discharge line β, an IN-LINE heater R is operated, and catalysts, which lose their activity, in the denitration device Q are regenerated. 
     COPYRIGHT: (C)1980,JPO&Japio